{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T07:04:08Z","timestamp":1793257448737,"version":"4.5.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["pharmrev.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reviews"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.pharmr.2024.100007","type":"journal-article","created":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T19:08:59Z","timestamp":1735326539000},"page":"100007","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Carbonic anhydrase inhibitors: \u201cOld\u201d drugs with new potential in unexpected areas"],"prefix":"10.1016","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3004-5675","authenticated-orcid":false,"given":"Ali H.","family":"Eid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmr.2024.100007_bib1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0031-6997(25)06962-5","article-title":"Carbonic anhydrase inhibitors","volume":"8","author":"Berliner","year":"1956","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pharmr.2024.100007_bib2","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3109\/14756366.2014.910202","article-title":"An overview of the alpha-, beta- and gamma-carbonic anhydrases from Bacteria: can bacterial carbonic anhydrases shed new light on evolution of bacteria?","volume":"30","author":"Capasso","year":"2015","journal-title":"J\u00a0Enzyme Inhib Med Chem"},{"key":"10.1016\/j.pharmr.2024.100007_bib3","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/13543776.2023.2205586","article-title":"The management of Babesia, amoeba and other zoonotic diseases provoked by protozoa","volume":"33","author":"Capasso","year":"2023","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.pharmr.2024.100007_bib4","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1080\/13543776.2024.2332663","article-title":"Carbonic anhydrase and bacterial metabolism: a chance for antibacterial drug discovery","volume":"34","author":"Capasso","year":"2024","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.pharmr.2024.100007_bib5","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.4155\/fmc-2021-0207","article-title":"Bacterial carbonic anhydrases: underexploited antibacterial therapeutic targets","volume":"13","author":"Flaherty","year":"2021","journal-title":"Future Med Chem"},{"key":"10.1016\/j.pharmr.2024.100007_bib6","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1152\/physrev.1967.47.4.595","article-title":"Carbonic anhydrase: chemistry, physiology, and inhibition","volume":"47","author":"Maren","year":"1967","journal-title":"Physiol Rev"},{"key":"10.1016\/j.pharmr.2024.100007_bib7","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/COC.0000000000000691","article-title":"A\u00a0phase 1 study of SLC-0111, a novel inhibitor of carbonic anhydrase IX, in patients with advanced solid tumors","volume":"43","author":"McDonald","year":"2020","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.pharmr.2024.100007_bib8","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s10741-024-10417-7","article-title":"Acetazolamide therapy in patients with acute heart failure: a systematic review and meta-analysis of randomized controlled trials","volume":"29","author":"Milbradt","year":"2024","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.pharmr.2024.100007_bib9","doi-asserted-by":"crossref","DOI":"10.1124\/pharmrev.124.001125","article-title":"Multi- and poly-pharmacology of carbonic anhydrase inhibitors","volume":"77","author":"Supuran","year":"2025","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pharmr.2024.100007_bib10","article-title":"Acetazolamide and human carbonic anhydrases: retrospect, review and discussion of an intimate relationship","volume":"39","author":"Tsikas","year":"2024","journal-title":"J\u00a0Enzyme Inhib Med Chem"}],"container-title":["Pharmacological Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699724116079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699724116079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T16:25:48Z","timestamp":1750955148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031699724116079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0031699724116079"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmr.2024.100007","relation":{},"ISSN":["0031-6997"],"issn-type":[{"value":"0031-6997","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Carbonic anhydrase inhibitors: \u201cOld\u201d drugs with new potential in unexpected areas","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmr.2024.100007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1124\/pharmrev.124.001125","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100007"}}